540 related articles for article (PubMed ID: 31046810)
1. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
2. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
Trials; 2018 May; 19(1):297. PubMed ID: 29843781
[TBL] [Abstract][Full Text] [Related]
4. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
5. Safe shortening of antibiotic treatment duration for complicated
Buis D; van Werkhoven CH; van Agtmael MA; Bax HI; Berrevoets M; de Boer M; Bonten M; Bosmans JE; Branger J; Douiyeb S; Gelinck L; Jong E; Lammers A; Van der Meer J; Oosterheert JJ; Sieswerda E; Soetekouw R; Stalenhoef JE; Van der Vaart TW; Bij de Vaate EA; Verkaik NJ; Van Vonderen M; De Vries PJ; Prins JM; Sigaloff K;
BMJ Open; 2023 Apr; 13(4):e068295. PubMed ID: 37085305
[TBL] [Abstract][Full Text] [Related]
6. Long-term Staphylococcus aureus decolonization in patients on home parenteral nutrition: study protocol for a randomized multicenter trial.
Gompelman M; Wouters Y; Kievit W; Hopman J; Wertheim HF; Bleeker-Rovers CP; Wanten GJA
Trials; 2018 Jun; 19(1):346. PubMed ID: 29954418
[TBL] [Abstract][Full Text] [Related]
7. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
[TBL] [Abstract][Full Text] [Related]
8. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
9. Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection.
Kaasch AJ; Rommerskirchen A; Hellmich M; Fätkenheuer G; Prinz-Langenohl R; Rieg S; Kern WV; Seifert H;
Trials; 2020 Feb; 21(1):175. PubMed ID: 32051007
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
Fätkenheuer G; Preuss M; Salzberger B; Schmeisser N; Cornely OA; Wisplinghoff H; Seifert H
Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):157-62. PubMed ID: 14986158
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocol.
Daneman N; Rishu AH; Pinto RL; Arabi YM; Cook DJ; Hall R; McGuinness S; Muscedere J; Parke R; Reynolds S; Rogers B; Shehabi Y; Fowler RA;
BMJ Open; 2020 May; 10(5):e038300. PubMed ID: 32398341
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
13. Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.
Holland TL; Raad I; Boucher HW; Anderson DJ; Cosgrove SE; Aycock PS; Baddley JW; Chaftari AM; Chow SC; Chu VH; Carugati M; Cook P; Corey GR; Crowley AL; Daly J; Gu J; Hachem R; Horton J; Jenkins TC; Levine D; Miro JM; Pericas JM; Riska P; Rubin Z; Rupp ME; Schrank J; Sims M; Wray D; Zervos M; Fowler VG;
JAMA; 2018 Sep; 320(12):1249-1258. PubMed ID: 30264119
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.
Daneman N; Rishu AH; Xiong W; Bagshaw SM; Cook DJ; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Stelfox HT; Fowler RA;
Trials; 2015 Apr; 16():173. PubMed ID: 25903783
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
[TBL] [Abstract][Full Text] [Related]
17. 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial.
Daneman N; Rishu AH; Pinto R; Aslanian P; Bagshaw SM; Carignan A; Charbonney E; Coburn B; Cook DJ; Detsky ME; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Sligl W; Stelfox HT; Wilcox ME; Fowler RA;
Trials; 2018 Feb; 19(1):111. PubMed ID: 29452598
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.
Ma H; Cheng J; Peng L; Gao Y; Zhang G; Luo Z
PLoS One; 2020; 15(3):e0230383. PubMed ID: 32191760
[TBL] [Abstract][Full Text] [Related]
19.
Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
[TBL] [Abstract][Full Text] [Related]
20. Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.
Turner NA; Zaharoff S; King H; Evans S; Hamasaki T; Lodise T; Ghazaryan V; Beresnev T; Riccobene T; Patel R; Doernberg SB; Rappo U; Fowler VG; Holland TL;
Trials; 2022 May; 23(1):407. PubMed ID: 35578360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
